Basal cell carcinoma of the prostate: clinicopathologic analysis of three cases and a review of the literature

World J Surg Oncol. 2013 Aug 13;11(1):193. doi: 10.1186/1477-7819-11-193.

Abstract

Background: Although conventional adenocarcinoma accounts for the majority of prostatic carcinomas, it is important to recognize rare variants, like basal cell carcinoma (BCC), which has distinctive histopathological and biological features.

Case report: We analyzed three cases of prostatic BCC and all of them complained of acute urinary retention and digital rectal examination disclosed a stony hard prostate. However, all of them presented with low prostate-specific antigen. The diagnosis relied on transrectal ultrasound-guided needle biopsies or transurethral resection of the prostate (TURP). The microscopic findings suggested basaloid cells with large pleomorphic nuclei and scant cytoplasm, showing peripheral palisading and forming solid nests, and immunohistochemical markers like 34βE12, p63 and Ki67 staining, were positive. After active treatment, two of the patients are alive with tumor and one died five months after discharge from our hospital.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Biomarkers, Tumor / analysis
  • Bone Neoplasms / complications
  • Bone Neoplasms / secondary*
  • Bone Neoplasms / therapy
  • Carcinoma, Basal Cell / complications
  • Carcinoma, Basal Cell / pathology*
  • Carcinoma, Basal Cell / therapy
  • Combined Modality Therapy
  • Humans
  • Immunoenzyme Techniques
  • Liver Neoplasms / complications
  • Liver Neoplasms / secondary*
  • Liver Neoplasms / therapy
  • Lung Neoplasms / complications
  • Lung Neoplasms / secondary*
  • Lung Neoplasms / therapy
  • Male
  • Middle Aged
  • Prognosis
  • Prostatic Neoplasms / complications
  • Prostatic Neoplasms / pathology*
  • Prostatic Neoplasms / therapy
  • Retrospective Studies
  • Review Literature as Topic
  • Transurethral Resection of Prostate

Substances

  • Biomarkers, Tumor